Cystine 186-cystine 209 disulfide bond is not essential for the procoagulant activity of tissue factor or for its de-encryption

Blood

Volumn 115, Issue 21, 2010, Pages 4273-4283

  Kothari, Hema ^a   Nayak, Ramesh C ^a   Rao, L Vijaya Mohan ^a   Pendurthi, Usha R ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; CYSTINE; CYSTINE 186 CYSTINE 209; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; DISULFIDE; MERCURIC CHLORIDE; MUTANT PROTEIN; PHOSPHATIDYLSERINE; PRIMER DNA; RECOMBINANT PROTEIN; THROMBOPLASTIN;

ANIMAL CELL; ANTIBODY DETECTION; ANTICOAGULATION; ARTICLE; BIOTINYLATION; CELL SURFACE; CHO CELL; CONFOCAL MICROSCOPY; DISULFIDE BOND; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS; UMBILICAL VEIN; WILD TYPE; ANIMAL; CELL CULTURE; CELL LINE; CELL MEMBRANE; CELL STRAIN HL 60; CHEMISTRY; CRICETULUS; DIMERIZATION; GENETICS; HAMSTER; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN QUATERNARY STRUCTURE;

ANIMALS; BASE SEQUENCE; CELL LINE; CELL MEMBRANE; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; CYSTINE; DIMERIZATION; DISULFIDES; DNA PRIMERS; ENDOTHELIAL CELLS; FACTOR VIIA; HL-60 CELLS; HUMANS; MERCURIC CHLORIDE; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; PHOSPHATIDYLSERINES; PROTEIN STRUCTURE, QUATERNARY; RECOMBINANT PROTEINS; THROMBOPLASTIN; TRANSFECTION;

EID: 77953625529     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-09-241356     Document Type: Article

References (41)

1. Rapaport SI, Rao LVM. The tissue factor pathway: how it has become a "prima ballerina." Thromb Haemost. 1995;74(1):7-17.
2. Konigsberg W, Kirchhofer D, Riederer MA, Nemerson Y. The TF:VIIa complex: clinical significance, structure-function relationships and its role in signaling and metastasis. Thromb Haemost. 2001;86(3):757-771. (Pubitemid 32834183)
3. Taubman MB, Fallon JT, Schecter AD, et al. Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost. 1997;78(1):200-204.
4. Belting M, Ahamed J, Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler Thromb Vasc Biol. 2005;25(8):1545-1550.
5. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol. 2004;24(6):1015-1022.
6. Morrissey JH. Tissue factor: an enzyme cofactor and a true receptor. Thromb Haemost. 2001;86(1):66-74.
7. Le DT, Rapaport SI, Rao LVM. Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces. J Biol Chem. 1992;267(22):15447-15454.
8. Bach R, Rifkin DB. Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc Natl Acad Sci U S A. 1990;87(18):6995- 6999. (Pubitemid 20325192)
9. Wolberg AS, Monroe DM, Roberts HR, Hoffmann MR. Tissue factor de-encryption:ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms. Blood Coag Fibrinol. 1999;10(4):201-210.
10. Bach RR. Tissue factor encryption. Arterioscler Thromb Vasc Biol. 2006;26(3):456-461.
11. Broze GJ Jr. Binding of human factor VII and VIIa to monocytes. J Clin Invest. 1982;70(3):526-535.
12. Ploplis VA, Edgington TS, Fair DS. Initiation of the extrinsic pathway of coagulation. Association of factor VIIa with a cell line expressing tissue factor. J Biol Chem. 1987;262(20):9503-9508.
13. Sakai T, Lund-Hansen T, Paborsky L, Pedersen AH, Kisiel W. Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). J Biol Chem. 1989;264(17):9980-9988.
14. Le DT, Rapaport SI, Rao LVM. Studies of the mechanism for enhanced cell surface factor VIIa/tissue factor activation of factor X in fibroblast monolayers after their exposure to N-ethylmalemide. Thromb Haemost. 1994;72(6):848-855.
15. Pendurthi UR, Ghosh S, Mandal SK, Rao LV. Tissue factor activation: is disulfide bond switching a regulatory mechanism? Blood. 2007;110(12):3900-3908.
16. Rao LVM, Pendurthi UR. Tissue factor on cells. Blood Coag Fibrin. 1998;9(suppl 1):S27-S35.
17. Bach RR, Moldow CF. Mechanism of tissue factor activation on HL-60 cells. Blood. 1997;89(9):3270-3276. (Pubitemid 27229812)
18. Mandal SK, Iakhiaev A, Pendurthi UR, Rao LV. Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol. Blood. 2005;105(1):153-160.
19. Dietzen DJ, Page KL, Tetzloff TA. Lipid rafts are necessary for tonic inhibition of cellular tissue factor procoagulant activity. Blood. 2004;103(8):3038-3044.
20. del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood. 2005;106(5):1604-1611.
21. Egorina EM, Sovershaev MA, Osterud B. Regulation of tissue factor procoagulant activity by post-translational modifications. Thromb Res. 2008;122(6):831-837.
22. Chen VM, Ahamed J, Versteeg HH, et al. Evidence for activation of tissue factor by an allosteric disulfide bond. Biochem. 2006;45(39):12020-12028.
23. Ahamed J, Versteeg HH, Kerver M, et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci U SA. 2006;103(38):13932-13937. (Pubitemid 44452960)
24. Liang HPH, Hogg PJ. Critical importance of the cell system when studying tissue factor deencryption. Blood. 2008;112(3):912-913.
25. Pendurthi UR, Rao LVM. Tissue factor de-encryption: the cell model system. Blood. 2008;112(3):913.
26. Reinhardt C, von Bruhl ML, Manukyan D, et al. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest. 2008;118(3):1110-1122.
27. Cho J, Furie BC, Coughlin SR, Furie B. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest. 2008;118(3):1123-1131.
28. Butenas S, Orfeo T, Mann KG. Tissue factor in coagulation: Which? Where? When? Arterioscler Thromb Vasc Biol. 2009;29(12):1989-1996.
29. Bach RR, Monroe D. What is wrong with the allosteric disulfide bond hypothesis? Arterioscler Thromb Vasc Biol. 2009;29(12):1997-1998.
30. Rehemtulla A, Ruf W, Edgington TS. The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII. J Biol Chem. 1991;266(16):10294-10299. (Pubitemid 21906802)
31. Rao LVM. Characterization of anti-tissue factor antibody and its use in immunoaffinity purification of human tissue factor. Thromb Res. 1988;51(4):373-384.
32. Ghosh S, Pendurthi UR, Steinoe A, Esmon CT, Rao LV. Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium. J Biol Chem. 2007;282(16):11849-11857.
33. Mandal SK, Pendurthi UR, Rao LVM. Cellular localization and trafficking of tissue factor. Blood. 2006;107(12):4746-4753.
34. Greeno EW, Bach R, Moldow CF. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest. 1996;75(2):281-289. (Pubitemid 26272366)
35. Kaneko H, Kakkar VV, Scully MF. Mercury compounds induce a rapid increase in procoagulant activity of monocyte-like U937 cells. Br J Haematol. 1994;87(1):87-93. (Pubitemid 24207004)
36. Mamathambika BS, Bardwell JC. Disulfide-linked protein folding pathways. Annu Rev Cell Dev Biol. 2008;24:211-235.
37. Hampton RY. ER-associated degradation in protein quality control and cellular regulation. Curr Opin Cell Biol. 2002;14(4):476-482.
38. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature. 2003;426(6968):895-899.
39. Schmidt B, Ho L, Hogg PJ. Allosteric disulfide bonds. Biochemistry. 2006;45(24):7429-7433.
40. Bach R, Konigsberg WH, Nemerson Y. Human tissue factor contains thioester-linked palmitate and sterate on the cytoplasmic half-cystine. Biochemistry. 1988;14(12):4227-4231.
41. Paborsky LR, Harris RJ. Post-translational modifications of recombinant human tissue factor. Thromb Res. 1990;60(5):367-376.